BioPortfolio - ONCOMEMBRANE Incorporated
ONCOMEMBRANE Incorporated - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/7812-ONCOMEMBRANE_I...
|
Drug Approvals for October 1997
Applicant: ONCOMEMBRANE INC Active Ingredient(s): FERRIC AMMONIUM CITRATE OTC/RX Status: RX Indication(s): For use with T1-weighted magnetic resonance ...
http://www.fda.gov/cder/da/da1097.htm...
|
BioPortfolio - ONCOMEMBRANE Incorporated - Profile
View the current ONCOMEMBRANE Incorporated Page on BioPortfolio.com. (http://www .bioportfolio.com/biocorporate/7812-ONCOMEMBRANE+Incorporated.html) ...
http://www.bioportfolio.com/biocorporate/7812-ONCOMEMBRANE+I...
|
Drug Approvals for November 1996
Trade Name: FERRISELTZ Dosage Form: POWDER, FOR ORAL SOLUTION Applicant: ONCOMEMBRANE INC Active Ingredient(s): FERRIC AMMONIUM CITRATE BROWN ...
http://www.fda.gov/CDER/da/da1196.htm...
|
BioPortfolio - NeoGenex
View full profile · ONCOMEMBRANE Incorporated ... View full profile · University of Puget Sound ... View full profile . ...
http://www.bioportfolio.com/search/NeoGenex.html...
|
Prescription and Over-the-Counter Drug Product List - 18th Edition
... 1997 > DLT > + ONCOMEMBRANE 600MG/PACKET N20292 001 SOLUTION; ORAL > DLT > OCT 14, 1997 NEORAL > ADD > AB + NOVARTIS 100MG/ML N50716 001 > ADD > JUL 14,
...
http://www.fda.gov/CDER/rxotcdpl/pdpl_1098.htm...
|
Pharmaceutical, Life Science, Medical, Biotechnology, Healthcare ...
ONCOMEMBRANE Incorporated · OncorMed Incorporated · Oncotest GmbH · Oncotherapeutics Incorporated · One Cell Systems Incorporated · One Lambda
Incorporated ...
http://www.bioportfolio.com/biotechnology/BioCorporate_Direc...
|
New Drug Approval Packages
FerriSeltz/Ferric Ammonium Citrate, Brown Part 1 [11.4 MB] Part 2 [8.1 MB], Oncomembrane, Inc. 020292, 10/14/1997, 2/4/1998 ...
http://www.fda.gov/CDER/foi/nda/index97.htm...
|
PAGE 1
7993 ONCOMEMBRANE, INC. 0404 ONCOR, INC. 1729 ONCOTECH INCORPORATED. 5731 ONCURA , INC. 7223 ONE LAMBDA/MICRODROP INC. 3758 ONECOSMOS ...
http://www.ucop.edu/raohome/sponsors/rpts/CGX1125.pdf...
|
Appendix D (List of Approved Applications): PDUFA FY 98 ...
CITRATE, Oncomembrane, 22.9, FDA First Action: 12.0 (AE) Sponsor Response: 4.9 FDA Second Action: 6.0 (AP), Y Y. FY 96, LAMOTRIGINE, Glaxo Wellcome, 23.2 ...
http://www.fda.gov/ope/pdufa/report98/appendd.htm...
|
